Clinical Trial Update: VEGF Trap in Treating Patients With Solid Tumors or Non-Hodgkin's Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating VEGF Trap (aflibercept) in patients with solid tumors or Non-Hodgkin's lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• VEGF Trap (aflibercept)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | Status: COMPLETED